/
NXGL
$0.55+$0.00 (+0.44%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$4.8M
9M shares
52-week range
$0.48 – $2.89
3% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-3.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $717.0K | $674.0K | $1.6M | $2.0M | $4.1M | $8.7M | $11.4M |
| Cost of revenue | $1.7M | $854.0K | $965.0K | $1.5M | $1.8M | $3.7M | $5.9M | $6.9M |
| Gross profit | $514.0K | −$137.0K | −$291.0K | $8.0K | $256.0K | $374.0K | $2.7M | $4.5M |
| Gross margin | 23.2% | -19.1% | -43.2% | 0.5% | 12.5% | 9.1% | 31.6% | 39.5% |
| R&D | $0 | $0 | $0 | $31.0K | $367.0K | $103.0K | $78.0K | $2.0K |
| Operating income | −$1.9M | −$1.9M | −$2.3M | −$2.6M | −$3.3M | −$3.5M | −$3.6M | −$3.4M |
| EBITDA | −$1.6M | −$1.9M | −$2.2M | −$2.2M | −$3.1M | −$2.7M | −$2.9M | −$2.1M |
| Net income | −$1.9M | −$1.9M | −$2.3M | −$4.3M | −$4.7M | −$3.2M | −$3.3M | −$3.0M |
| Net margin | -85.3% | -268.2% | -335.9% | -277.9% | -231.7% | -77.2% | -37.8% | -26.3% |
| EPS (diluted) | -0.34 | -0.35 | -0.41 | -0.77 | -0.85 | -0.56 | -0.50 | -0.38 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $24M | $-0.12 | $-0.12–$-0.12 | 1 |
| 2027 | $34M | $0.40 | $0.40–$0.40 | 1 |
| 2028 | $37M | $0.29 | $0.29–$0.29 | 1 |
| 2029 | $40M | $0.35 | $0.35–$0.35 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
NexGel, Inc Common Stock
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
www.nexgel.com- Employees
- 19
- IPO / List date
- Dec 22, 2021
- HQ
- LANGHORNE, PA
Held by traders on TradeandTell
No one on the platform currently holds NXGL.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 50,960 | $32.3K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NXGL yet.
